Cell treatment with siRNAs targeting SCD1 expression (siSCD1) complexed with Lipofectamine RNAiMAX had essentially no effect on the viability of U87 and U373 human glioblastoma cells when cultured in regular growth medium, which contains 10% FBS (Figure 2A). The gene discussed is SCD; the disease is glioblastoma.